Skip to main content
main-content
Top

25-02-2020 | Pregnancy | News

guidelinesWatch

ACR issues guidelines on reproductive health in people with rheumatic diseases

Author: Claire Barnard

share
SHARE
print
PRINT
insite
SEARCH

medwireNews: The ACR has released guidelines for reproductive healthcare among people with rheumatic and musculoskeletal diseases (RMD).

“This guideline’s most important goal is to provide substance and direction for discussion between clinicians and patients,” and a “second goal is to encourage development of close working relationships” among rheumatology, obstetrics/gynecology, maternal–fetal medicine, and fertility specialists, say Lisa Sammaritano (Hospital for Special Surgery, New York, USA) and co-authors.

The guidelines, published simultaneously in Arthritis & Rheumatology and Arthritis Care & Research, provide twelve good practice statements and 131 graded recommendations covering contraception use, pre-pregnancy counselling, and regular physician–patient communication.

Sammaritano and colleagues note that “[t]he strength of evidence on reproductive health topics in RMD patients is moderate at best, and usually low, very low or nonexistent for many topics of interest,” and outline priorities for future research, which should include better understanding of the effects of RMD medication on male fertility, and large-scale studies on RMD drug use in women around the time of pregnancy.

medwireNews is an independent medical news service provided by Springer Healthcare. © 2020 Springer Healthcare part of the Springer Nature group

Arthritis Rheumatol 2020; doi:10.1002/art.41191
Arthritis Care Res 2020; doi:10.1002/acr.24130

share
SHARE
print
PRINT

New additions to the Adis Journal Club

A monthly selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

Rituximab and rheumatology practice in the COVID-19 era

How can rheumatologists respond to the challenges associated with rituximab use during the pandemic?